Follow The Filings

DDS Dillard's

Dillard's earnings company data as of 4:48 AM ET 10/5

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 12 Nov EPS 7.80 — —
Rev — — —
FY2026 Q2 13 Aug EPS 4.21 — —
Rev — — —

Insider trades

Open-market buys and sales by DDS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DDS insider trades
  • None no insider bought on the open market
  • $244K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. J C Watts Jr. Director
    Sale
    $244K 400 shares at $609.18 3.8% of stake
    Traded Jun 5 Filed Jun 5
    ↗
  2. J C Watts Jr. Director
    Sale
    $446K 750 shares at $594.60 6.8% of stake
    Traded Oct 16, 2025 Filed Oct 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 166 stock grants, 18 gifts, and 4 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
8-K 3.01,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 24 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.